Bitcoin halving
What does that mean?
$2.79T
Total marketcap
$120.39B
Total volume
BTC 49.84%     ETH 15.32%
Dominance

Terumo Corporation TRUMY Stock

36.78 USD {{ price }} -1.552665% {{change_pct}}%
Exchange
Other OTC
Market Cap
27.3B USD
LOW - HIGH [24H]
34.3 - 37.52 USD
VOLUME [24H]
16.66K USD
{{ volume }}
P/E Ratio
83.57
Earnings per share
0.44 USD

Terumo Corporation Price Chart

Terumo Corporation TRUMY Financial and Trading Overview

Terumo Corporation stock price 36.78 USD
Previous Close 32.58 USD
Open 32.52 USD
Bid 0 USD x 0
Ask 0 USD x 0
Day's Range 32.52 - 32.78 USD
52 Week Range 25.59 - 35.79 USD
Volume 13.35K USD
Avg. Volume 42.5K USD
Market Cap 24.06B USD
Beta (5Y Monthly) 0.462835
PE Ratio (TTM) 39.48193
EPS (TTM) 0.44 USD
Forward Dividend & Yield 0.27 (0.83%)
Ex-Dividend Date September 29, 2022
1y Target Est N/A

TRUMY Valuation Measures

Enterprise Value 68.87B USD
Trailing P/E 39.48193
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm) 0.029333863
Price/Book (mrq) 0.02196166
Enterprise Value/Revenue 0.084
Enterprise Value/EBITDA 0.357

Trading Information

Terumo Corporation Stock Price History

Beta (5Y Monthly) 0.462835
52-Week Change 15.87%
S&P500 52-Week Change 20.43%
52 Week High 35.79 USD
52 Week Low 25.59 USD
50-Day Moving Average 30.22 USD
200-Day Moving Average 29.07 USD

TRUMY Share Statistics

Avg. Volume (3 month) 42.5K USD
Avg. Daily Volume (10-Days) 23.31K USD
Shares Outstanding 734.2M
Float 729.72M
Short Ratio N/A
% Held by Insiders 0%
% Held by Institutions 0.0050%
Shares Short N/A
Short % of Float N/A
Short % of Shares Outstanding N/A

Dividends & Splits

Trailing Annual Dividend Rate 40
Trailing Annual Dividend Yield 122.77%
5 Year Average Dividend Yield 78.00%
Payout Ratio 0.3156
Last Split Factor 2:1

Financial Highlights

Fiscal Year

Fiscal Year Ends March 31, 2023
Most Recent Quarter (mrq) March 31, 2023
Next Fiscal Year End March 31, 2024

Profitability

Profit Margin 10.89%
Operating Margin (ttm) 14.95%
Gross Margin 50.88%
EBITDA Margin 23.51%

Management Effectiveness

Return on Assets (ttm) 4.98%
Return on Equity (ttm) 8.41%

Income Statement

Revenue (ttm) 820.21B USD
Revenue Per Share (ttm) 1092.72 USD
Quarterly Revenue Growth (yoy) 12.50%
Gross Profit (ttm) 417.37B USD
EBITDA 192.91B USD
Net Income Avi to Common (ttm) 89.33B USD
Diluted EPS (ttm) 0.83
Quarterly Earnings Growth (yoy) 11.79%

Balance Sheet

Total Cash (mrq) 187.32B USD
Total Cash Per Share (mrq) 251.57 USD
Total Debt (mrq) 231.94B USD
Total Debt/Equity (mrq) 20.88 USD
Current Ratio (mrq) 2.805
Book Value Per Share (mrq) 1492.146

Cash Flow Statement

Operating Cash Flow (ttm) 117.54B USD
Levered Free Cash Flow (ttm) 31.79B USD

Profile of Terumo Corporation

Country United States
State N/A
City Tokyo
Address 2-44-1, Hatagaya
ZIP 151-0072
Phone 81 3 3374 8111
Website https://www.terumo.co.jp
Industry Medical Instruments & Supplies
Sector(s) Healthcare
Full Time Employees N/A

Terumo Corporation engages in the manufacture and sale of medical products and equipment worldwide. The company operates through three segments: Cardiac and Vascular Company, Medical Care Solutions Company, and Blood and Cell Technologies Company. The Cardiac and Vascular Company segment offers angiographic guidewires, angiographic catheters, introducer sheaths, vascular closure devices, PTCA balloon catheters, coronary stents, self-expanding peripheral stents, intravascular ultrasound systems, imaging catheters, and others; coils, stents, and intrasaccular devices for treating cerebral aneurysm; embolization systems, aspiration catheters, and clot retrievers for treating ischemic stroke and others; oxygenators, cardio-pulmonary bypass systems, and others; and artificial vascular and stent grafts. The Medical Care Solutions Company segment provides syringes, infusion pumps, syringe pumps, infusion lines, I.V. solutions, peritoneal dialysis fluids, pain management and nutritious food products, adhesion barriers, and others; blood glucose monitoring systems, disposable needles for pen-injector, insulin patch pumps, blood pressure monitors, digital thermometers, and others; and contract manufacturing of prefilled syringes, devices to pharmaceutical companies for use in drug kits, such as prefillable syringes, needles for pharmaceutical packaging business, and others. The Blood and Cell Technologies Company segment offers blood bags, component collection systems, automated blood processing systems, pathogen reduction systems, centrifugal apheresis systems, cell expansion systems, and others. The company was formerly known as Sekisen Ken-onki Corporation and changed its name to Terumo Corporation in October 1974. Terumo Corporation was incorporated in 1921 and is headquartered in Tokyo, Japan.

Q&A For Terumo Corporation Stock

What is a current TRUMY stock price?

Terumo Corporation TRUMY stock price today per share is 36.78 USD.

How to purchase Terumo Corporation stock?

You can buy TRUMY shares on the Other OTC exchange. Contact your financial advisor to select a broker.

What is the ticker symbol for Terumo Corporation?

The stock symbol or ticker of Terumo Corporation is TRUMY.

Which industry does the Terumo Corporation company belong to?

The Terumo Corporation industry is Medical Instruments & Supplies.

How many shares does Terumo Corporation have in circulation?

The max supply of Terumo Corporation shares is 742.49M.

What is Terumo Corporation Price to Earnings Ratio (PE Ratio)?

Terumo Corporation PE Ratio is 83.57955000 now.

What was Terumo Corporation earnings per share over the trailing 12 months (TTM)?

Terumo Corporation EPS is 0.44 USD over the trailing 12 months.

Which sector does the Terumo Corporation company belong to?

The Terumo Corporation sector is Healthcare.